Report Feature
- Kits & Reagents
- Filtration Systems
- Services
- Other Products
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Biological
- Vaccine & Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Stem Cell Products
- Medical Devices
- Air Purification
- Water Purification
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic Research Institutes
- Medical Device Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the virus filtration companies profiled in this report include Merck, General Electric, Thermo Fisher Scientific, Lonza, Pall, Charles River Laboratories, Sigma-Aldrich, Sartorius, Asahi Kasei Medical, and WuXi PharmaTech.
Lucintel forecasts that kits & reagents will remain the largest product segment over the forecast period due to increasing focus on development of vaccines, protein therapeutics, and blood products.
Within this market, pharmaceutical & biotechnology companies will remain the largest segment by end user over the forecast period due to rising research and development activities and increasing production of biologics.
North America will remain the largest region over the forecast period due to increasing prevalance of chronic diseases, rising research and development activities in biopharmaceutical industries, and growing demand for biologics in the region.
|
Features of the Global Virus Filtration Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global virus filtration market by product (kits & reagents, filtration systems, services, and other products), application (biological (vaccine & therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products, and stem cell products), medical devices, air purification, and water purification), end user (pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global virus filtration market? Q.5 What are the business risks and threats to the global virus filtration market? Q.6 What are the emerging trends in this virus filtration market and the reasons behind them? Q.7 What are some changing demands of customers in this virus filtration market? Q.8 What are the new developments in this virus filtration market? Which companies are leading these developments? Q.9 Who are the major players in this virus filtration market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this virus filtration market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global virus filtration market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Kits & Reagents, Filtration Systems, Services, and Other Products), Application (Biological, Medical Devices, Air Purification, and Water Purification), and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, and Medical Device Companies) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.